Citations (6)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (2)
Rupesh Raina, Manpreet K Grewal, Yeshwanter Radhakrishnan, Vineeth Tatineni, Meredith DeCoy, Linda LG Burke & Arvind Bagga. (2019) Optimal management of atypical hemolytic uremic disease: challenges and solutions. International Journal of Nephrology and Renovascular Disease 12, pages 183-204.
Read now
Read now
Anwesha A. Mukherjee, Amit D. Kandhare & Subhash L. Bodhankar. (2018) Evaluation of health-related quality of life in hemolytic uraemic syndrome patients treated with eculizumab: a systematic evaluation on basis of EMPRO. Renal Failure 40:1, pages 107-118.
Read now
Read now
Articles from other publishers (4)
Rupesh Raina, Sidharth K. Sethi, Marie-Agnès Dragon-Durey, Amrit Khooblall, Divya Sharma, Priyanka Khandelwal, Ron Shapiro, Olivia Boyer, Hui Kim Yap, Arvind Bagga & Christoph Licht. (2022) Systematic review of atypical hemolytic uremic syndrome biomarkers. Pediatric Nephrology 37:7, pages 1479-1493.
Crossref
Crossref
Cristina Giorgio, Mara Zippoli, Pasquale Cocchiaro, Vanessa Castelli, Giustino Varrassi, Andrea Aramini, Marcello Allegretti, Laura Brandolini & Maria Candida Cesta. (2021) Emerging Role of C5 Complement Pathway in Peripheral Neuropathies: Current Treatments and Future Perspectives. Biomedicines 9:4, pages 399.
Crossref
Crossref
Everardo Arias Torres, Yongen Chang, Sheetal Desai, Ian Chang, Jonathan E. Zuckerman, Richard Burwick, Kamyar Kalantar-Zadeh & Ramy M. Hanna. (2021) Complement-Mediated Thrombotic Microangiopathy Associated with Lupus Nephritis Treated with Eculizumab: A Case Report. Case Reports in Nephrology and Dialysis 11:1, pages 95-102.
Crossref
Crossref
A. V. Smirnov, A. V. Karunnaya & V. A. Dobronravov. (2017) Nephrological aspects of complement-mediated thrombotic microangiopathy. Terapevticheskii arkhiv 89:6, pages 34.
Crossref
Crossref